Bringing Good Things To Life (Science)?

Bringing Good Things To Life (Science)? Infiltrating ductal carcinoma tissue labeled with both H&E (hematoxylin and eosin) staining and clinical biomarkers. Image courtesy of GE Global Research A series of purchases is turning General Electric, the world's second largest company, into a major supplier of life sciences equipment. By Brendan Borrell Related Articles Vaccine Dreams Gee Whiz, that's GE! Seeing faster, seeing smar

Written byBrendan Borrell
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

By Brendan Borrell

Vaccine Dreams

Gee Whiz, that's GE!

Seeing faster, seeing smarter

Slideshow: GE lights up life science

In the spring of 2005, a team of applied physicists and electrical engineers from the General Electric Company filed into pathology laboratories at the Memorial Sloan-Kettering Cancer Center, taking notes on their clipboards and clicking their stopwatches. Day after day, they went from laboratory to laboratory to watch as clinical researchers section and stain tissue - "Click" - examine it under a fluorescent microscope - "Click" - take digital images - "Click" - analyze expression patterns or scribble diagnoses.

"I had worked in these lab environments," says Michael Montalto, a biologist at GE, "but nobody else at GE had. So, I knew it was important that these scientists had an idea as to what the market was going to look like." Montalto's team, working on GE's first Advanced Technology initiative, analyzed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies